Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06VYK
|
|||
| Drug Name |
Azithromycin
|
|||
| Synonyms |
azithromycin; Zithromax; 83905-01-5; Sumamed; Zitromax; Zmax; Azithromycinum; Azithromycine; Hemomycin; Azitrocin; Azasite; Azenil; Zitrotek; Misultina; Zithrax; Azitromax; Mixoterin; Setron; Aziwok; Zitrim; Tromix; Aztrin; Zifin; Tobil; Zmas; Zeto; Azithromycinum [Latin]; Azithromycine [French]; Zithromax IV; AZITHROMYCIN DIHYDRATE; CP-62993; Z-Pak; Aritromicina [Spanish]; CP 62993; UNII-J2KLZ20U1M; DRG-0104; C38H72N2O12; CCRIS 1961; HSDB 7205; Azithromycin (anhydrous); BRN 5387583; J2KLZ20U1M; Azythromycin; CHEBI:2955; Azithromycin (AIDS Initiative; Azithromycin
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Bronchitis [ICD-11: CA20; ICD-10: J40] | Approved | [1] | |
| Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | Phase 3 | [2] | ||
| Therapeutic Class |
Antiviral Agents
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C38H72N2O12
|
|||
| Canonical SMILES |
CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
|
|||
| InChI |
1S/C38H72N2O12/c1-15-27-38(10,46)31(42)24(6)40(13)19-20(2)17-36(8,45)33(52-35-29(41)26(39(11)12)16-21(3)48-35)22(4)30(23(5)34(44)50-27)51-28-18-37(9,47-14)32(43)25(7)49-28/h20-33,35,41-43,45-46H,15-19H2,1-14H3/t20-,21-,22+,23-,24-,25+,26+,27-,28+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1
|
|||
| InChIKey |
MQTOSJVFKKJCRP-BICOPXKESA-N
|
|||
| CAS Number |
CAS 83905-01-5
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:2955
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (ANDA) 065511. | |||
| REF 2 | ClinicalTrials.gov (NCT04332107) Azithromycin for COVID-19 Treatment in Outpatients Nationwide. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.